AIDS Healthcare Foundation
Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials
2007 · Bonaventura Clotet, Nicholas Bellos, et al. · The Lancet
Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48
2008 · Roberto Ortiz, Edwin DeJesus, et al. · AIDS
Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1
2015 · Mark Sulkowski, Joseph J. Eron, et al. · JAMA